New Delhi, March 8 A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).Cipla USA, Inc, based in Warren (New Jersey), is recalling Nilotinib Capsules in...
anti-cancer medication
cancer treatment
ciplacipla usa, inc
class iii recall
drug supply
generic medication
manufacturing defect
nilotinib
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical recall
us food and drug administration (usfda)
us prescription drugs
warren (new jersey)
New Delhi, February 10 Drug maker Cipla said that the US health regulator has issued Form 483 with two observations after inspecting a manufacturing facility of its US-based unit, InvaGen Pharmaceuticals, Inc.A Pre-Approval Inspection was conducted by the US Food and Drug Administration...